BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23690672)

  • 1. Differential IL-13 production by small intestinal leukocytes in active coeliac disease versus refractory coeliac disease.
    Gross S; van Wanrooij RL; Nijeboer P; Gelderman KA; Cillessen SA; Meijer GA; Mulder CJ; Bouma G; von Blomberg BM; Bontkes HJ
    Mediators Inflamm; 2013; 2013():939047. PubMed ID: 23690672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal T cell receptor gene rearrangements in coeliac disease: implications for diagnosing refractory coeliac disease.
    Hussein S; Gindin T; Lagana SM; Arguelles-Grande C; Krishnareddy S; Alobeid B; Lewis SK; Mansukhani MM; Green PHR; Bhagat G
    J Clin Pathol; 2018 Sep; 71(9):825-831. PubMed ID: 29703761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant T-lymphocytes in refractory coeliac disease are not strictly confined to a small intestinal intraepithelial localization.
    Verbeek WH; von Blomberg BM; Coupe VM; Daum S; Mulder CJ; Schreurs MW
    Cytometry B Clin Cytom; 2009 Nov; 76(6):367-74. PubMed ID: 19444812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells promote expansion and survival of aberrant TCR-negative intraepithelial lymphocyte lines from refractory celiac disease type II patients.
    Schmitz F; Tjon JM; van Bergen J; Koning F
    Mol Immunol; 2014 Mar; 58(1):10-6. PubMed ID: 24252355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease.
    Di Sabatino A; Ciccocioppo R; Cupelli F; Cinque B; Millimaggi D; Clarkson MM; Paulli M; Cifone MG; Corazza GR
    Gut; 2006 Apr; 55(4):469-77. PubMed ID: 16105889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of interleukin-4 and interleukin-10 and their association with the lymphocytic infiltrate in the small intestine of patients with coeliac disease.
    Beckett CG; Dell'Olio D; Kontakou M; Przemioslo RT; Rosen-Bronson S; Ciclitira PJ
    Gut; 1996 Dec; 39(6):818-23. PubMed ID: 9038663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the cytokine profile in the duodenal mucosa of refractory coeliac disease patients.
    Caruso R; Marafini I; Sedda S; Del Vecchio Blanco G; Giuffrida P; MacDonald TT; Corazza GR; Pallone F; Di Sabatino A; Monteleone G
    Clin Sci (Lond); 2014 Mar; 126(6):451-8. PubMed ID: 24125165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory cytokines in small intestinal mucosa of patients with potential coeliac disease.
    Westerholm-Ormio M; Garioch J; Ketola I; Savilahti E
    Clin Exp Immunol; 2002 Apr; 128(1):94-101. PubMed ID: 11982596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum cytokine elevations in celiac disease: association with disease presentation.
    Manavalan JS; Hernandez L; Shah JG; Konikkara J; Naiyer AJ; Lee AR; Ciaccio E; Minaya MT; Green PH; Bhagat G
    Hum Immunol; 2010 Jan; 71(1):50-7. PubMed ID: 19735687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of elemental diet on mucosal immunopathology and clinical symptoms in type 1 refractory celiac disease.
    Olaussen RW; Løvik A; Tollefsen S; Andresen PA; Vatn MH; De Lange T; Bratlie J; Brandtzaeg P; Farstad IN; Lundin KE
    Clin Gastroenterol Hepatol; 2005 Sep; 3(9):875-85. PubMed ID: 16234025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4 T-cell cytokines synergize to induce proliferation of malignant and nonmalignant innate intraepithelial lymphocytes.
    Kooy-Winkelaar YM; Bouwer D; Janssen GM; Thompson A; Brugman MH; Schmitz F; de Ru AH; van Gils T; Bouma G; van Rood JJ; van Veelen PA; Mearin ML; Mulder CJ; Koning F; van Bergen J
    Proc Natl Acad Sci U S A; 2017 Feb; 114(6):E980-E989. PubMed ID: 28049849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A locus at 7p14.3 predisposes to refractory celiac disease progression from celiac disease.
    Hrdlickova B; Mulder CJ; Malamut G; Meresse B; Platteel M; Kamatani Y; Ricaño-Ponce I; van Wanrooij RLJ; Zorro MM; Jan Bonder M; Gutierrez-Achury J; Cellier C; Zhernakova A; Nijeboer P; Galan P; Withoff S; Lathrop M; Bouma G; Xavier RJ; Jabri B; Bensussan NC; Wijmenga C; Kumar V
    Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):828-837. PubMed ID: 29787419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small-intestinal TG2-specific plasma cells at different stages of coeliac disease.
    Hietikko M; Koskinen O; Kurppa K; Laurila K; Saavalainen P; Salmi T; Ilus T; Huhtala H; Kaukinen K; Lindfors K
    BMC Immunol; 2018 Dec; 19(1):36. PubMed ID: 30522434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a potential physiological precursor of aberrant cells in refractory coeliac disease type II.
    Schmitz F; Tjon JM; Lai Y; Thompson A; Kooy-Winkelaar Y; Lemmers RJ; Verspaget HW; Mearin ML; Staal FJ; Schreurs MW; Cupedo T; Langerak AW; Mulder CJ; van Bergen J; Koning F
    Gut; 2013 Apr; 62(4):509-19. PubMed ID: 22760007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of small intestinal interleukin-17 immunity in untreated coeliac disease but not in potential coeliac disease or in type 1 diabetes.
    Lahdenperä AI; Hölttä V; Ruohtula T; Salo HM; Orivuori L; Westerholm-Ormio M; Savilahti E; Fälth-Magnusson K; Högberg L; Ludvigsson J; Vaarala O
    Clin Exp Immunol; 2012 Feb; 167(2):226-34. PubMed ID: 22235998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refractory Celiac Disease.
    Malamut G; Cellier C
    Gastroenterol Clin North Am; 2019 Mar; 48(1):137-144. PubMed ID: 30711206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired control of effector T cells by regulatory T cells: a clue to loss of oral tolerance and autoimmunity in celiac disease?
    Hmida NB; Ben Ahmed M; Moussa A; Rejeb MB; Said Y; Kourda N; Meresse B; Abdeladhim M; Louzir H; Cerf-Bensussan N
    Am J Gastroenterol; 2012 Apr; 107(4):604-11. PubMed ID: 22108452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transglutaminase 2 expression is enhanced synergistically by interferon-γ and tumour necrosis factor-α in human small intestine.
    Bayardo M; Punzi F; Bondar C; Chopita N; Chirdo F
    Clin Exp Immunol; 2012 Apr; 168(1):95-104. PubMed ID: 22385244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gluten-induced nitric oxide and pro-inflammatory cytokine release by cultured coeliac small intestinal biopsies.
    Beckett CG; Dell'Olio D; Shidrawi RG; Rosen-Bronson S; Ciclitira PJ
    Eur J Gastroenterol Hepatol; 1999 May; 11(5):529-35. PubMed ID: 10755257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on the diagnosis and management of refractory coeliac disease.
    Nijeboer P; van Wanrooij RL; Tack GJ; Mulder CJ; Bouma G
    Gastroenterol Res Pract; 2013; 2013():518483. PubMed ID: 23762036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.